Delivery of timolol through artificial membranes and pig stratum corneum

Journal of Pharmaceutical Sciences

Volumn 92, Issue 5, 2003, Pages 1037-1039

  Stamatialis, Dimitrios F ^a   Rolevink, H H M ^a   Koops, G H ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Artificial membranes; Iontophoresis; Pig stratum corneum; Timolol

Indexed keywords

TIMOLOL;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; IN VITRO STUDY; IONTOPHORESIS; NONHUMAN; POROSITY; STRATUM CORNEUM;

EID: 0037406518     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10387     Document Type: Article

References (7)

1. Banga AK. 1998. Percutaneous absorption and its enhancement. Chapter 1. In: Rubinstein MH, Wilson CG, Todd JP, editors. Electrically assisted transdermal and topical drug delivery. London: Taylor & Francis Ltd.
2. U.S. Pat. 5167616 (1992); Haak RP, Yieh J, Gyory RJ, (Applicant Alza Corp., US) Iontophoretic delivery method.
3. U.S. Pat. 5322502 (1992); Theeuwes F, Gyory RJ, Haak RP (Applicant Alza Corp., US). Membrane for electrotransport transdermal drug delivery.
4. Stamatialis DF, Rolevink HHM, Koops GH. 2002. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions. J Controlled Release 81:335-345.
5. Guy RH, Hadgraft J. 1992. Rate control in transdermal drug delivery? Int J Pharm 82: R1-R6.
6. Li GL, Danhof M, Bouwstra JA. 2001. Iontophoretic delivery of apomorphine in vitro: Physicochemic considerations. Pharm Res 18:1509-1513.
7. van der Geest R, Danhof M, Bodde HE. 1998. Validation and testing of a new iontophoretic continuous flow through transport cell. J Controlled Release 51:85-91.